BeOne Medicines Ltd. 4

SVP, General Counsel Lee Chan Henry sold 1,044 American Depositary Shares of BeOne Medicines Ltd. on July 30, 2026 in a tax-withholding transaction tied to RSU vesting.

On July 30, 2026, SVP and General Counsel Lee Chan Henry of BeOne Medicines Ltd. disposed of 1,044 American Depositary Shares (each representing 13 Ordinary Shares) at an average price of $323.69 per ADS, for proceeds of approximately $337,000. The transaction was a sale triggered by mandatory tax withholding associated with the vesting of a previously granted restricted share unit award, rather than a discretionary open-market sale. Following the transaction, the reporting person beneficially owns 325,312 Ordinary Shares (or the ADS equivalent), with the remaining unvested portion of the award continuing to vest in annual installments through July 29, 2026, subject to continued service and certain accelerated vesting provisions on specified termination events.

Filing Facts

CIK

1651308

Ticker

ONC

Form

4

Source Type

fda

Accession

0001980648-26-000021

Alert Tier

5